| Jul 26 |
New MultiCenter Prospective Study Demonstrates Signatera’s Clinical Utility in Merkel Cell Carcinoma
|
| Jul 25 |
Natera (NTRA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
| Jul 12 |
Injunction again NeoGenomics over RaDaR assay affirmed by appeals court
|
| Jul 3 |
Natera (NTRA) Soared After a 43% Increase In Revenue
|
| Jul 3 |
Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy
|
| Jul 3 |
Natera's (NASDAQ:NTRA) investors will be pleased with their massive 314% return over the last five years
|
| Jul 3 |
Insider Sale: CEO and President Steven Chapman Sells 37,500 Shares of Natera Inc (NTRA)
|
| Jun 27 |
Natera Announces DECIPHER: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer
|
| Jun 20 |
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
|
| Jun 19 |
Insider Selling: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
|
